BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30399204)

  • 1. Pre-operative predictors of early recurrence/mortality including the role of inflammatory indices in patients undergoing partial hepatectomy for spontaneously ruptured hepatocellular carcinoma.
    Chua DW; Koh YX; Liew YX; Chan CY; Lee SY; Cheow PC; Chow PK; Chung AY; Ooi LL; Goh BK
    J Surg Oncol; 2018 Dec; 118(8):1227-1236. PubMed ID: 30399204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and prognostic nutrition index as preoperative predictors of early mortality after liver resection for huge (≥10 cm) hepatocellular carcinoma.
    Goh BK; Kam JH; Lee SY; Chan CY; Allen JC; Jeyaraj P; Cheow PC; Chow PK; Ooi LL; Chung AY
    J Surg Oncol; 2016 May; 113(6):621-7. PubMed ID: 26861568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological risk factors for recurrence within one year after initial hepatectomy for hepatocellular carcinoma.
    Hayashi M; Shimizu T; Hirokawa F; Inoue Y; Komeda K; Asakuma M; Miyamoto Y; Takeshita A; Shibayama Y; Tanigawa N
    Am Surg; 2011 May; 77(5):572-8. PubMed ID: 21679590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
    Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
    Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.
    Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK
    World J Gastroenterol; 2014 Dec; 20(45):17132-40. PubMed ID: 25493027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.
    Pang Q; Zhang JY; Xu XS; Song SD; Qu K; Chen W; Zhou YY; Miao RC; Liu SS; Dong YF; Liu C
    World J Gastroenterol; 2015 May; 21(18):5607-21. PubMed ID: 25987786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is serum alpha-fetoprotein useful for predicting recurrence and mortality specific to hepatocellular carcinoma after hepatectomy? A test based on propensity scores and competing risks analysis.
    Shim JH; Yoon DL; Han S; Lee YJ; Lee SG; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS
    Ann Surg Oncol; 2012 Nov; 19(12):3687-96. PubMed ID: 22644512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
    Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
    World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
    World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma.
    Nakanishi K; Sakamoto M; Yamasaki S; Todo S; Hirohashi S
    Cancer; 2005 Jan; 103(2):307-12. PubMed ID: 15593087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy.
    Ruan DY; Lin ZX; Li Y; Jiang N; Li X; Wu DH; Wang TT; Chen J; Lin Q; Wu XY
    World J Gastroenterol; 2015 May; 21(18):5598-606. PubMed ID: 25987785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-operative predictors of post-hepatectomy recurrence of hepatocellular carcinoma: can we predict earlier?
    Chong CC; Lee KF; Ip PC; Wong JS; Cheung SY; Wong J; Ho SC; Lai PB
    Surgeon; 2012 Oct; 10(5):260-6. PubMed ID: 22959159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous rupture of hepatocellular carcinoma: Optimal timing of partial hepatectomy.
    Wu JJ; Zhu P; Zhang ZG; Zhang BX; Shu C; Mba'nbo-Koumpa AA; Zhang ZW; Huang ZY; Zhang WG; Lau WY; Chen XP
    Eur J Surg Oncol; 2019 Oct; 45(10):1887-1894. PubMed ID: 31405632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence After Liver Transplantation for Hepatocellular Carcinoma: A New MORAL to the Story.
    Halazun KJ; Najjar M; Abdelmessih RM; Samstein B; Griesemer AD; Guarrera JV; Kato T; Verna EC; Emond JC; Brown RS
    Ann Surg; 2017 Mar; 265(3):557-564. PubMed ID: 27611615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of fibroblast growth factor 19 is associated with recurrence and poor prognosis of hepatocellular carcinoma.
    Hyeon J; Ahn S; Lee JJ; Song DH; Park CK
    Dig Dis Sci; 2013 Jul; 58(7):1916-22. PubMed ID: 23456506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of spontaneous rupture on the survival outcomes after liver resection for hepatocellular carcinoma: A propensity matched analysis comparing ruptured versus non-ruptured tumors.
    Chua DW; Koh YX; Allen JC; Chan CY; Lee SY; Cheow PC; Jeyaraj P; Teo JY; Chow PK; Chung AY; Ooi LL; Goh BKP
    Eur J Surg Oncol; 2019 Sep; 45(9):1652-1659. PubMed ID: 31003720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatectomy for hepatocellular carcinoma larger than 10 cm: preoperative risk stratification to prevent futile surgery.
    Lim C; Compagnon P; Sebagh M; Salloum C; Calderaro J; Luciani A; Pascal G; Laurent A; Levesque E; Maggi U; Feray C; Cherqui D; Castaing D; Azoulay D
    HPB (Oxford); 2015 Jul; 17(7):611-23. PubMed ID: 25980326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prognostic factors influencing postoperative survival in patients with Wu FS; Zhao WH; Liang TB; Ren GP; Ma ZM; Teng LS
    Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):579-83. PubMed ID: 15938929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.
    Katz SC; Shia J; Liau KH; Gonen M; Ruo L; Jarnagin WR; Fong Y; D'Angelica MI; Blumgart LH; Dematteo RP
    Ann Surg; 2009 Apr; 249(4):617-23. PubMed ID: 19300227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.